Clinical variants of lesions of the nervous system in ANCA-associated vasculitis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Systemic vasculitis (SV) is a group of diseases united by the presence of inflammation of the vascular wall. Neurological manifestations may occur at the onset of SV or at the stage of multiple organ damage. Diagnosis of central and peripheral nervous system lesions in ANCA-associated vasculitis is based on neurological examination data and the results of laboratory and instrumental research methods.

Full Text

Restricted Access

About the authors

V. V Oganov

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia

Email: strizhakov76@mail.ru

S. A Mamykina

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia

Email: strizhakov76@mail.ru

O. E Zinovyeva

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia

Email: strizhakov76@mail.ru

доктор медицинских наук, профессор

L. A Strizhakov

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia; M.V. Lomonosov Moscow State University

Email: strizhakov76@mail.ru

P. I Novikov

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia

Email: strizhakov76@mail.ru

кандидат медицинских наук

S. V Moiseev

I.M. Sechenov First Moscow State Medical University (Sechenov University) Ministry of Health of the Russia; M.V. Lomonosov Moscow State University

Author for correspondence.
Email: strizhakov76@mail.ru

доктор медицинских наук, профессор

References

  1. Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol. 2016; 3 (3): 122-33. doi: 10.5152/eurjrheum.2015.0043
  2. Nataraja A., Mukhtyar C., Hellmich B. et al. Outpatient assessment of systemic vasculitis. Best Pract Res Clin Rheumatol. 2007; 21 (4): 713-32. doi: 10.1016/j.berh.2007.01.004
  3. Новиков П.И., Моисеев С.В. Рекомендации Британского ревматологического общества / Британской ассоциации ревматологов по лечению АНЦА-ассоциированных васкулитов у взрослых. Клиническая фармакология и терапия. 2014; 23 (5): 97-104.
  4. Moog P., Eren O., Witt M. et al. Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis. Clin Auton Res. 2016; 26 (4): 279-85. DOI: 10.1007/ s10286-016-0364-8
  5. Greco A., De Virgilio A., Rizzo M.I. et al. Microscopic polyangiitis: Advances in diagnostic and therapeutic approaches. Autoimmun Rev. 2015; 14 (9): 837-44. DOI: 10.1016/j. autrev.2015.05.005
  6. Choi H.A., Lee M.J., Chung C.S. Characteristics of hypertrophic pachymeningitis in patients with granulomatosis with polyangiitis. J Neurol. 2017; 264 (4): 724-32. DOI: 10.1007/ s00415-017-8416-0
  7. Grygiel-Gorniak B., Limphaibool N., Perkowska K. et al. Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features. Postgrad Med. 2018; 130 (7): 581-96. doi: 10.1080/00325481.2018.1503920
  8. Fragoulis G.E., Lionaki S., Venetsanopoulou A. et al. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol. 2018; 37 (3): 737-47. doi: 10.1007/s10067-017-3835-y
  9. Lutalo P.M., D'Cruz D.P. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). J Autoimmun. 2014; 48-49 :94-8. DOI: 10.1016/j. jaut.2014.01.028
  10. Morozumi S., Koike H., Tomita M. et al. Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J Neuropathol Exp Neurol. 2011; 70 (5): 340-8. doi: 10.1097/NEN.0b013e3182172290
  11. Chung S.A., Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am. 2010; 36 (3): 545-58. doi: 10.1016/j.rdc.2010.04.003
  12. Karras A. Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy. Semin Respir Crit Care Med. 2018; 39 (4): 459-64. doi: 10.1055/s-0038-1673387
  13. Nakamoto K., Saraya T., Ogawa Y. et al.Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis. Respir Med. 2018; 139: 101-5. DOI: 10.1016/j. rmed.2018.05.003
  14. Новиков П.И., Семенкова Е.Н., Моисеев С.В. Современная номенклатура системных васкулитов. Клиническая фармакология и терапия. 2013; 33 (1): 70-4.
  15. Smith R.M., Jones R.B., Jayne D.R. Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther. 2012; 14 (2): 210. doi: 10.1186/ar3797
  16. Vaglio A., Buzio C., Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy. 2013; 68 (3): 261-73. doi: 10.1111/all.12088
  17. Andre R., Cottin V., Saraux J.L. et al. French Vasculitis Study Group (FVSG). Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev. 2017; 16 (9): 963-9. doi: 10.1016/j.autrev.2017.07.007
  18. Lepse N., Abdulahad W.H., Kallenberg C.G. et al. Immune regulatory mechanisms in ANCA-associated vasculitides. Autoimmun Rev. 2011; 11 (2): 77-83. DOI: 10.1016/j. autrev.2011.08.002
  19. Nishi R., Koike H., Ohyama K. et al. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA. Neurology. 2020; 94 (16): 1726-37. doi: 10.1212/WNL.0000000000009309
  20. Koike H., Sobue G. Clinicopathological features of neuropathy in anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Nephrol. 2013; 17 (5): 683-5. doi: 10.1007/s10157-012-0767-3
  21. Geetha D., Jefferson J.A. ANCA-Associated Vasculitis: Core Curriculum 2020. Am J Kidney Dis. 2020; 75 (1): 124-37. doi: 10.1053/j.ajkd.2019.04.031
  22. Takeuchi H., Kawasaki T., Shigematsu K. et al. Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis. Clin Rheumatol. 2017; 36 (4): 913-7. doi: 10.1007/s10067-017-3546-4
  23. Graf J. Central Nervous System Disease in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis. Rheum Dis Clin North Am. 2017; 43 (4): 573-8. DOI: 10.1016/j. rdc.2017.06.006
  24. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2013; 12 (4): 487-95. doi: 10.1016/j.autrev.2012.08.008
  25. Hansrivijit P., Trongtorsak A., Gadhiya K.P. et al. Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression. Clin Rheumatol. 2021; 40 (7): 2843-53. doi: 10.1007/s10067-021-05589-8
  26. Стрижаков Л.А., Моисеев С.В., Коган Е. А. и др. Поражение сердца при системных васкулитах: патогенетические механизмы, значение факторов риска сердечно-сосудистых осложнений и диагностика. Тер арх. 2014; 86 (12): 35-42.
  27. Моисеев С.В., Новиков П.И., Мешков А.Д. и др. АНЦА-ассоциированные васкулиты: спорные вопросы классификации, диагностики и оценки активности и современные подходы к лечению. Клиническая фармакология и терапия. 2014; 23 (1): 44-50.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies